GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemiaAdriano Venditti, Sergio Amadori, Mario Luppi et al.|Blood|2019Cited by 215
Diagnostic capabilities, clinical features, and longitudinal <scp><i>UBA1</i></scp> clonal dynamics of a nationwide <scp>VEXAS</scp> cohortCarmelo Gurnari, Maria Teresa Voso, Maria Rosaria Pascale et al.|American Journal of Hematology|2023Cited by 43
Monosomal karyotype in myeloid neoplasias: a literature reviewLuisa Anelli, Francesco Albano|OncoTargets and Therapy|2017Cited by 17
In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalentMichele Baccarani, Francesco Passamonti, Ilaria Iacobucci et al.|Leukemia|2019Cited by 9
Epitranscriptomics in Normal and Malignant HematopoiesisCrescenzio Francesco Minervini, Francesco Albano|International Journal of Molecular Sciences|2020Cited by 6